Catalog Number 115309 |
Device Problem
Device Contamination with Chemical or Other Material (2944)
|
Patient Problem
No Patient Involvement (2645)
|
Event Date 11/16/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Prismaflex st100 set ckt has been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that during priming with a prismaflex st100, a particle (not further described) was observed in the filter pot.There was no patient involvement.No additional information is available.
|
|
Manufacturer Narrative
|
Correction added: the event was reported to have occurred on (b)(6) 2020.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Manufacturer Narrative
|
H10: the device was received and a photograph of the sample was provided for evaluation.The visual inspection of the provided picture showed the presence of a whitish precipitate in the access circuit of the set.The whitish precipitate observed on the picture provided by the customer was confirmed on the sample received.The reported condition was verified.It can be stated that the presence of anticoagulant futhan caused the observed white precipitate to form in the priming solution.The cause is therefore not device related.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Search Alerts/Recalls
|